Type 2 Diabetes Mellitus

Dr. Hammid Bashir

Dr. Hammid Bashir, PhD, is a laboratory specialist and biochemist at the Government Medical College since 2012. His research background is in biochemistry, with extensive experience and a deep understanding of Type 2 Diabetes Mellitus. He has published approximately 49 articles and is a co-editor of three recently published books. He is a rising researcher focused on Thyroid Diseases, Diabetes, and Insulin Resistance.

Shafat Ali (Ph.D.)

Shafat Ali, Ph.D., earned his BSc. from the University of Kashmir and his Master’s in Zoology from Barkatullah Vishwavidyalaya, India. He has five years of research experience and five years of teaching experience. Currently, he is engaged in research at the Cytogenetics and Molecular Biology Laboratory, Centre of Research for Development, University of Kashmir, Department of Biochemistry, Government Medical College, Srinagar, Jammu and Kashmir, and the ICMR funded Multidisciplinary Research Unit, Government Medical College, Srinagar, Jammu and Kashmir, India. His specialization lies in reproductive immunogenetics, cytokine biology, gynaecology and obstetrics, molecular biology, cancer biology, and cytogenetics. He has contributed over 20 book chapters, several edited books, and numerous peer-reviewed international research publications. Mr. Ali also serves as a reviewer for many reputed international journals. Presently, he is investigating the immunogenetic mechanisms involved in recurrent pregnancy loss.

Dr. Yahya F. Jamous

Dr. Yahya F. Jamous is a Saudi pharmaceutical scientist and researcher currently working at the Wellness and Preventive Medicine Institute, King Abdulaziz City of Science and Technology (KACST), Riyadh. With over 15 years in research and teaching, he has a strong record of scientific publications in pharmaceutical biotechnology, nanotechnology, and molecular pharmacology. Dr. Jamous has held various high-ranking academic and administrative positions at KACST, including Associate Research Professor, Assistant Research Professor, Acting Director of National Partnerships, and former Director of the National Vaccines and Bioprocessing Centre (NVBC), supporting programs aligned with Saudi Vision 2030. He holds a PhD in Molecular Pharmacology from ETH Zurich, focusing on new therapeutic targets in heart failure, and MSc and BSc degrees in Pharmaceutical Sciences from King Saud University. Dr. Jamous is a licensed Consultant of Pharmaceutical Sciences.